Search Results

Spherical Insights: Global Dyspepsia Drugs Market Size to Be Worth USD 14.7 Billion by 2033.

• Source: Professional Services Close-Up. 2024.

Record details

Spherical Insights: Global Dyspepsia Drugs Market Size to Be Worth USD 14.7 Billion by 2033.

• Source: Entertainment Close-up. 2024.

Record details

Spherical Insights: Global Dyspepsia Drugs Market Size to Be Worth USD 14.7 Billion by 2033.

• Source: Travel & Leisure Close-Up. 2024.

Record details

Spherical Insights: Global Dyspepsia Drugs Market Size to Be Worth USD 14.7 Billion by 2033.

• Source: Food & Beverage Close-Up. 2024.

Record details

Researcher at Universitas Kristen Indonesia Has Published New Data on Dyspepsia (Description of Urea and Creatinine Levels in Dyspepsia Patients Taking Proton Pump Inhibitor Drugs at the Indonesian Christian University Hospital in 2018)

• Source: Obesity, Fitness & Wellness Week. March 23, 2024, 4670

Record details

Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%.

• Source: Financial Services Monitor Worldwide. 2024.

Record details

Curcumin, Omeprazole Similarly Effective for Functional Dyspepsia

• Source: MPR Monthly Prescribing Reference. September 15, 2023

Record details

New Findings from Umm Al-Qura University in the Area of Functional Dyspepsia Described (Design and Evaluation of S-Protected Thiolated-Based Itopride Hydrochloride Polymeric Nanocrystals for Functional Dyspepsia: QbD-Driven Optimization, In ...)

• Source: Obesity, Fitness & Wellness Week. August 19, 2023, p2588

Record details

Review article: endpoints used in functional dyspepsia drug therapy trials.

• Authors : Ang D; Center for Gastroenterological Research, Department of Pathophysiology, Division of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, Leuven, Belgium.; Talley NJ

Subjects: Severity of Illness Index*; Dyspepsia/Dyspepsia/Dyspepsia/*drug therapy ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*therapeutic use

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2011 Mar; Vol. 33 (6), pp. 634-49. Date of Electronic Publication: 2011 Jan 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Gastroesophageal reflux disease and dyspepsia--drug therapy].

• Authors : Gräter H; Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin, Städtische Kliniken Esslingen.

Subjects: Proton Pump Inhibitors*; Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*therapeutic use ; Dyspepsia/Dyspepsia/Dyspepsia/*drug therapy

• Source: Praxis [Praxis (Bern 1994)] 2006 Aug 02; Vol. 95 (31-32), pp. 1179-83.Publisher: Aerzteverlag medinfo AG Country of Publication: Switzerland NLM ID: 101468093 Publication Model: Print Cited Medium: Print ISSN:

Record details